{"context":{"query":">>ensembl>>reactome","source_dataset":"ensembl","target_dataset":"reactome"},"stats":{"queried":5,"total":82,"mapped":5},"pagination":{"has_next":false},"schema":"id|name|tax_id|is_disease_pathway","mappings":[{"input":"ENSG00000162594","source":"ENSG00000162594|IL23R","targets":["R-HSA-6785807|Interleukin-4 and Interleukin-13 signaling|9606|false","R-HSA-9020933|Interleukin-23 signaling|9606|false"]},{"input":"ENSG00000167207","source":"ENSG00000167207|NOD2","targets":["R-HSA-168638|NOD1/2 Signaling Pathway|9606|false","R-HSA-445989|TAK1-dependent IKK and NF-kappa-B activation  |9606|false","R-HSA-450302|activated TAK1 mediates p38 MAPK activation|9606|false","R-HSA-450321|JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1|9606|false","R-HSA-5689896|Ovarian tumor domain proteases|9606|false","R-HSA-9020702|Interleukin-1 signaling|9606|false","R-HSA-9705671|SARS-CoV-2 activates/modulates innate and adaptive immune responses|9606|true"]},{"input":"ENSG00000187796","source":"ENSG00000187796|CARD9","targets":["R-HSA-168638|NOD1/2 Signaling Pathway|9606|false","R-HSA-5607764|CLEC7A (Dectin-1) signaling|9606|false","R-HSA-168249|Innate Immune System|9606|false","R-HSA-168256|Immune System|9606|false","R-HSA-168643|Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways|9606|false","R-HSA-5621481|C-type lectin receptors (CLRs)|9606|false"]},{"input":"ENSG00000085978","source":"ENSG00000085978|ATG16L1","targets":["R-HSA-1632852|Macroautophagy|9606|false","R-HSA-9612973|Autophagy|9606|false"]},{"input":"ENSG00000096968","source":"ENSG00000096968|JAK2","targets":["R-HSA-1059683|Interleukin-6 signaling|9606|false","R-HSA-110056|MAPK3 (ERK1) activation|9606|false","R-HSA-112411|MAPK1 (ERK2) activation|9606|false","R-HSA-1170546|Prolactin receptor signaling|9606|false","R-HSA-1433557|Signaling by SCF-KIT|9606|false","R-HSA-2586552|Signaling by Leptin|9606|false","R-HSA-3214858|RMTs methylate histone arginines|9606|false","R-HSA-512988|Interleukin-3, Interleukin-5 and GM-CSF signaling|9606|false","R-HSA-5673000|RAF activation|9606|false","R-HSA-5673001|RAF/MAP kinase cascade|9606|false","R-HSA-6785807|Interleukin-4 and Interleukin-13 signaling|9606|false","R-HSA-6788467|IL-6-type cytokine receptor ligand interactions|9606|false","R-HSA-6802946|Signaling by moderate kinase activity BRAF mutants|9606|true","R-HSA-6802952|Signaling by BRAF and RAF1 fusions|9606|true","R-HSA-6802955|Paradoxical activation of RAF signaling by kinase inactive BRAF|9606|true","R-HSA-69231|Cyclin D associated events in G1|9606|false","R-HSA-877300|Interferon gamma signaling|9606|false","R-HSA-877312|Regulation of IFNG signaling|9606|false","R-HSA-8854691|Interleukin-20 family signaling|9606|false","R-HSA-8984722|Interleukin-35 Signalling|9606|false","R-HSA-9006335|Signaling by Erythropoietin|9606|false","R-HSA-9020591|Interleukin-12 signaling|9606|false","R-HSA-9020933|Interleukin-23 signaling|9606|false","R-HSA-9020956|Interleukin-27 signaling|9606|false","R-HSA-9027276|Erythropoietin activates Phosphoinositide-3-kinase (PI3K)|9606|false","R-HSA-9027277|Erythropoietin activates Phospholipase C gamma (PLCG)|9606|false","R-HSA-9027283|Erythropoietin activates STAT5|9606|false","R-HSA-9027284|Erythropoietin activates RAS|9606|false","R-HSA-912526|Interleukin receptor SHC signaling|9606|false","R-HSA-9649948|Signaling downstream of RAS mutants|9606|true","R-HSA-9656223|Signaling by RAF1 mutants|9606|true","R-HSA-9670439|Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants|9606|true","R-HSA-9674555|Signaling by CSF3 (G-CSF)|9606|false","R-HSA-9679191|Potential therapeutics for SARS|9606|true","R-HSA-9705462|Inactivation of CSF3 (G-CSF) signaling|9606|false","R-HSA-9732724|IFNG signaling activates MAPKs|9606|false","R-HSA-982772|Growth hormone receptor signaling|9606|false","R-HSA-983231|Factors involved in megakaryocyte development and platelet production|9606|false","R-HSA-109582|Hemostasis|9606|false","R-HSA-112409|RAF-independent MAPK1/3 activation|9606|false","R-HSA-1280215|Cytokine Signaling in Immune system|9606|false","R-HSA-162582|Signal Transduction|9606|false","R-HSA-1640170|Cell Cycle|9606|false","R-HSA-1643685|Disease|9606|true","R-HSA-168256|Immune System|9606|false","R-HSA-3247509|Chromatin modifying enzymes|9606|false","R-HSA-447115|Interleukin-12 family signaling|9606|false","R-HSA-449147|Signaling by Interleukins|9606|false","R-HSA-451927|Interleukin-2 family signaling|9606|false","R-HSA-453279|Mitotic G1 phase and G1/S transition|9606|false","R-HSA-4839726|Chromatin organization|9606|false","R-HSA-5663202|Diseases of signal transduction by growth factor receptors and second messengers|9606|true","R-HSA-5663205|Infectious disease|9606|true","R-HSA-5683057|MAPK family signaling cascades|9606|false","R-HSA-5684996|MAPK1/MAPK3 signaling|9606|false","R-HSA-6783589|Interleukin-6 family signaling|9606|false","R-HSA-6802949|Signaling by RAS mutants|9606|true","R-HSA-6802957|Oncogenic MAPK signaling|9606|true","R-HSA-69236|G1 Phase|9606|false","R-HSA-69278|Cell Cycle, Mitotic|9606|false","R-HSA-9006934|Signaling by Receptor Tyrosine Kinases|9606|false","R-HSA-913531|Interferon Signaling|9606|false","R-HSA-9669938|Signaling by KIT in disease|9606|true","R-HSA-9679506|SARS-CoV Infections|9606|true","R-HSA-9824446|Viral Infection Pathways|9606|true"]}]}